Microbot Medical Inc. (MBOT)
NASDAQ: MBOT
· Real-Time Price · USD
3.13
0.00 (0.00%)
At close: Aug 15, 2025, 9:58 AM
Microbot Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 84K | n/a | n/a | n/a | 142K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 12K | 15K | 42K | 23K | 14K | 28K | 35K | 20K | 26K | 25K | 33K | 25K | 23K | 21K | 28K | 16K | 14K | 18K |
Gross Profit | -12K | -15K | 42K | -23K | -14K | -28K | -35K | -20K | -26K | -25K | -33K | -25K | -23K | -21K | -28K | -16K | -14K | -18K |
Operating Income | -3.72M | -3.02M | -3.43M | -3.3M | -2.51M | -2.38M | -2.07M | -2.54M | -2.32M | -2.92M | -3.07M | -3.47M | -3.56M | -3.18M | -3.94M | -2.55M | -2.48M | -2.39M |
Interest Income | n/a | 104K | 38K | 85K | 46K | 13K | n/a | 98K | 37K | n/a | 75K | 6K | 50K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.5M | -2.6M | -3.39M | -3.21M | -2.46M | -2.37M | -3.15M | -2.45M | -2.29M | -2.85M | -3M | -3.47M | -3.51M | -3.19M | -3.86M | -2.56M | -2.51M | -2.39M |
Net Income | -3.5M | -2.6M | -3.39M | -3.21M | -2.46M | -2.37M | -3.15M | -2.45M | -2.29M | -2.85M | -3M | -3.47M | -3.51M | -3.19M | -3.86M | -2.56M | -2.51M | -2.39M |
Selling & General & Admin | 1.61M | 1.56M | 1.45M | 1.24M | 1.09M | 1.22M | 938K | 932K | 959K | 1.3M | 1.41M | 1.52M | 1.37M | 1.47M | 1.89M | 1.16M | 1.09M | 1.27M |
Research & Development | 2.1M | 1.46M | 1.98M | 2.06M | 1.42M | 1.14M | 1.13M | 1.61M | 1.36M | 1.62M | 1.88M | 1.95M | 2.19M | 1.71M | 2.26M | 1.39M | 1.39M | 1.12M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 112K | n/a | n/a | n/a |
Operating Expenses | 3.71M | 3.02M | 3.43M | 3.3M | 2.51M | 2.36M | 2.07M | 2.54M | 2.32M | 2.92M | 3.07M | 3.47M | 3.56M | 3.18M | 3.94M | 2.55M | 2.48M | 2.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 66K | n/a | n/a | n/a | 7K | n/a | n/a | n/a | n/a | 3K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 224K | n/a | n/a | n/a | 206K | n/a | n/a | n/a |
Cost & Expenses | 3.72M | 3.02M | 3.43M | 3.3M | 2.51M | 2.38M | 2.07M | 2.54M | 2.32M | 2.92M | 3.07M | 3.47M | 3.56M | 3.18M | 3.94M | 2.55M | 2.48M | 2.39M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 36.49M | 17.02M | 17.02M | 16.47M | 14.85M | 14.06M | 12.13M | 11.71M | 9.2M | 7.92M | 7.72M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M |
Shares Outstanding (Diluted) | 36.49M | 17.02M | 17.02M | 16.47M | 14.85M | 14.06M | 12.13M | 11.71M | 9.2M | 8.01M | 7.72M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M | 7.11M |
EPS (Basic) | -0.1 | 0.01 | -0.2 | -0.2 | -0.17 | -0.17 | -0.26 | -0.21 | -0.25 | -0.36 | -0.39 | -0.49 | -0.49 | -0.45 | -0.54 | -0.36 | -0.35 | -0.34 |
EPS (Diluted) | -0.1 | 0.01 | -0.2 | -0.2 | -0.17 | -0.17 | -0.26 | -0.21 | -0.25 | -0.36 | -0.39 | -0.49 | -0.49 | -0.45 | -0.54 | -0.36 | -0.35 | -0.34 |
EBITDA | -3.49M | -2.59M | -3.4M | -3.28M | -2.5M | -2.36M | -2.31M | -2.52M | -2.3M | -2.89M | -3.04M | -3.45M | -3.54M | -3.15M | -3.91M | -2.54M | -2.46M | -2.37M |
EBIT | -3.5M | -2.6M | -3.43M | -3.3M | -2.51M | -2.38M | -2.35M | -2.54M | -2.32M | -2.92M | -3.07M | -3.47M | -3.56M | -3.18M | -3.94M | -2.55M | -2.48M | -2.39M |
Depreciation & Amortization | 12K | 15K | 26K | 23K | 14K | 28K | 35K | 20K | 26K | 25K | 33K | 25K | 23K | 21K | 28K | 16K | 14K | 18K |